Metabolic effects of reduced growth hormone action in fatty liver disease.
Rufinatscha K, Ress C, Folie S, Haas S, Salzmann K, Moser P, Dobner J, Weiss G, Iruzubieta P, Arias-Loste MT, Crespo J, Tilg H, Kaser S.
Rufinatscha K, et al. Among authors: kaser s.
Hepatol Int. 2018 Sep;12(5):474-481. doi: 10.1007/s12072-018-9893-7. Epub 2018 Sep 11.
Hepatol Int. 2018.
PMID: 30206761
Free PMC article.